الفهرس 
Frequency of skin lesions in the studied COVID-19 patientsOnly 14 pages are availabe for public view
 |  | from | 129 |  |  |
| | | from | 129 | | |
Abstract
Corona Virus-19 disease (COVID-19) marked the beginning of
a new pandemic coronavirus disease 2019 which has been declared on
11th of March 2019 by World Health Organization (WHO) after
massive numbers of acute pneumonia with unknown origin have been
reported.
Corona virus-19 from beta subgroup of SARS family is well
known for causing severe disease in lower respiratory tract and fecaloral
infectivity.
The main common symptoms that were reported caused by
COVID-19 were fever, fatigue, cough, production of sputum, muscle
aches, and lastly dyspnea; while other less common symptoms
reported were diarrhea, olfactory, and gustatory dysfunction.
Initially, there were no skin manifestations reported among
COVID-19 patients, however some patients who have been recently
confirmed as COVID-19 patients experienced some skin lesions
which could be a clinical sign of COVID-19.
COVID-19 associated skin lesions include pityriasis rosea like
lesions, vesicular like exanthema rash, erythema, petichea, urticarial
lesions, maculo-papules, livedo reticularis, and pseudo-chilblain.
The aim of this study was to determine the diversity of
cutaneous lesions caused by COVID-19 disease, and the onset of the
lesions in regards to the severity of the disease.
This was a prospective cohort study carried out on 1020
confirmed patients with COVID-19 disease during the isolation period
from March 2020 to March 2021 at El-Bagour Hospital. Our inclusion criteria were patients from both sexes of any age confirmed with
COVID-19 and experienced recent skin lesions.